Skip to content
Pricing
Sample Reports
Show submenu for Sample Reports
Company Report
Drug Report
Solutions
Show submenu for Solutions
Investors
Portfolio Managers
Research
Publisher Content
Resources
Show submenu for Resources
Case Studies
Demo Videos
Market Intelligence Datasets
Drug Index
FAQs
API Documentation
Company
Show submenu for Company
News & Updates
Leadership
CDD Vault
Contact Us
Login
Pricing
Sample Reports
Show submenu for Sample Reports
Company Report
Drug Report
Solutions
Show submenu for Solutions
Investors
Portfolio Managers
Research
Publisher Content
Resources
Show submenu for Resources
Case Studies
Demo Videos
Market Intelligence Datasets
Drug Index
FAQs
API Documentation
Company
Show submenu for Company
News & Updates
Leadership
CDD Vault
Contact Us
Nifurtimox
Lampit (nifurtimox) is a small molecule pharmaceutical. Nifurtimox was first approved as Lampit on 2020-08-06.
Trade Name
Lampit
Common Name
Nifurtimox
Indication
Drug Class
5-nitrofuran derivatives